Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 4/20 | 0.35 |
| ▸ | PPARD | Q03181 | 5/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 3/20 | 0.32 |
| ▸ | PPARA | Q07869 | 3/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6882094 | 1.00 | FFAR1 (0.35) | FFAR1PPARDPOLBTDP1PPARG | |
| SCHEMBL6566203 | 1.00 | FFAR1 (0.35) | FFAR1PPARDPOLBTDP1PPARG | |
| SCHEMBL6882719 | 0.88 | HDAC4 (0.32) | FFAR1HDAC4HDAC6BACE1MRGPRX4 | |
| SCHEMBL6562926 | 0.88 | HDAC4 (0.32) | FFAR1HDAC4HDAC6BACE1MRGPRX4 | |
| SCHEMBL6882723 | 0.88 | HDAC4 (0.32) | FFAR1HDAC4HDAC6BACE1MRGPRX4 | |
| SCHEMBL6883493 | 0.86 | PPARD (0.31) | FFAR1PPARDPPARGPPARA | |
| SCHEMBL6566268 | 0.86 | PPARD (0.31) | FFAR1PPARDPPARGPPARA | |
| SCHEMBL6883496 | 0.86 | PPARD (0.31) | FFAR1PPARDPPARGPPARA | |
| SCHEMBL6887623 | 0.86 | — | — | |
| SCHEMBL6887629 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6706725-B1 | BIAROMATIC COMPOUNDS WHICH ARE VITAMIN D ANALOGUES | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2004-03-16 | — | — | US | disclosed |